Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,644 SEK | -0.06% | -2.14% | +21.43% |
05-16 | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
05-16 | Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 1,679.50 | 1,679.50 | 1,679.50 |
Spread/Res. | -2.14% | -2.14% | -2.14% |
Spread/Supp. | +7.45% | +15.25% | +9.97% |
Support | 1,529.50 | 1,426.00 | 1,494.50 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- AZN Stock
- AZN Stock
- Charts AstraZeneca PLC